1.59
price up icon1.27%   0.02
pre-market  시장 영업 전:  1.59  
loading
전일 마감가:
$1.57
열려 있는:
$1.6
하루 거래량:
240.36K
Relative Volume:
1.20
시가총액:
$72.91M
수익:
$134.00K
순이익/손실:
$-9.93M
주가수익비율:
-4.6765
EPS:
-0.34
순현금흐름:
$-6.72M
1주 성능:
-18.04%
1개월 성능:
-26.05%
6개월 성능:
-13.11%
1년 성능:
-40.00%
1일 변동 폭
Value
$1.57
$1.6999
1주일 범위
Value
$1.57
$1.9875
52주 변동 폭
Value
$1.5006
$3.22

Entera Bio Ltd Stock (ENTX) Company Profile

Name
명칭
Entera Bio Ltd
Name
전화
972-2-532-7151
Name
주소
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Name
직원
22
Name
트위터
Name
다음 수익 날짜
2025-08-08
Name
최신 SEC 제출 서류
Name
ENTX's Discussions on Twitter

ENTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ENTX
Entera Bio Ltd
1.59 72.00M 134.00K -9.93M -6.72M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.15 118.84B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
812.27 81.61B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
422.50 53.69B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
822.94 49.49B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
176.00 37.34B 447.02M -1.18B -906.14M -6.1812

Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-03-22 개시 Aegis Capital Buy

Entera Bio Ltd 주식(ENTX)의 최신 뉴스

pulisher
Jan 04, 2026

Breakout Watch: Can Entera Bio Ltd 5DT stock surprise with quarterly results2025 Technical Overview & Low Drawdown Momentum Ideas - moha.gov.vn

Jan 04, 2026
pulisher
Jan 02, 2026

Entera Bio Ltd. (NASDAQ: ENTX) director reports 2026 share and option grants - Stock Titan

Jan 02, 2026
pulisher
Jan 02, 2026

Entera Bio (ENTX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Jan 02, 2026
pulisher
Dec 31, 2025

Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation - Yahoo Finance

Dec 31, 2025
pulisher
Dec 30, 2025

Entera Bio (NASDAQ:ENTX) CEO Miranda Jayne Toledano Acquires 11,000 Shares - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Entera Bio Ltd. Stock (ENTX) Opinions on Insider Buying and Clinical Updates - Quiver Quantitative

Dec 30, 2025
pulisher
Dec 30, 2025

ENTX Insider Trading - Quiver Quantitative

Dec 30, 2025
pulisher
Dec 28, 2025

Aug Retail: What margin trends mean for Entera Bio Ltd stockPortfolio Performance Report & Daily Risk Controlled Trade Plans - moha.gov.vn

Dec 28, 2025
pulisher
Dec 27, 2025

Entera Bio (NASDAQ:ENTX) Rating Increased to Sell at Wall Street Zen - MarketBeat

Dec 27, 2025
pulisher
Dec 26, 2025

FY2025 EPS Estimates for Entera Bio Boosted by HC Wainwright - Defense World

Dec 26, 2025
pulisher
Dec 25, 2025

HC Wainwright Increases Earnings Estimates for Entera Bio - MarketBeat

Dec 25, 2025
pulisher
Dec 24, 2025

H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint - Investing.com Australia

Dec 24, 2025
pulisher
Dec 23, 2025

Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation - marketscreener.com

Dec 23, 2025
pulisher
Dec 23, 2025

Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) - Sahm

Dec 23, 2025
pulisher
Dec 23, 2025

FDA clears new way to test osteoporosis drugs, aiming to cut trial time - Stock Titan

Dec 23, 2025
pulisher
Dec 22, 2025

Entera Bio’s oral PTH analog shows sustained calcium response By Investing.com - Investing.com Nigeria

Dec 22, 2025
pulisher
Dec 22, 2025

Entera Bio’s oral PTH analog shows sustained calcium response - Investing.com

Dec 22, 2025
pulisher
Dec 22, 2025

Entera Bio Ltd. Announces Promising Preclinical Data for Once-Daily Oral PTH Treatment in Hypoparathyroidism - Quiver Quantitative

Dec 22, 2025
pulisher
Dec 22, 2025

New once-a-day pill aims to replace daily injections for rare calcium disorder - Stock Titan

Dec 22, 2025
pulisher
Dec 22, 2025

Entera Bio Ltd. Announces New Data Supporting Further Development of A Proprietary First-In-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) - MarketScreener

Dec 22, 2025
pulisher
Dec 21, 2025

Can Entera Bio Ltd. stock beat analyst upgradesJuly 2025 Earnings & Safe Investment Capital Preservation Plans - Улправда

Dec 21, 2025
pulisher
Dec 21, 2025

How analysts rate Entera Bio Ltd. stock todayQuarterly Portfolio Report & Advanced Technical Analysis Signals - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

Can Entera Bio Ltd. stock sustain market leadership2025 Growth vs Value & Accurate Buy Signal Notifications - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Why Entera Bio Ltd. stock appeals to analystsJuly 2025 Update & Daily Volume Surge Trade Alerts - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Can Entera Bio Ltd. stock hit analyst price targets2025 Bull vs Bear & Expert Curated Trade Setups - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

How Entera Bio Ltd. stock trades before earningsWeekly Investment Summary & Smart Swing Trading Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Will Entera Bio Ltd. stock remain a Wall Street favoriteJuly 2025 Market Mood & Fast Gain Stock Tips - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Day Trade: Can Entera Bio Ltd. stock beat analyst upgrades2025 Key Lessons & Stepwise Trade Signal Guides - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Is Entera Bio Ltd. stock oversold or undervaluedDividend Hike & Verified Momentum Watchlists - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Chart Watch: Can Entera Bio Ltd. stock sustain market leadershipIndex Update & Verified Momentum Stock Alerts - Улправда

Dec 18, 2025
pulisher
Dec 12, 2025

Pharma News: Will Entera Bio Ltd stock outperform Dow Jones indexNew Guidance & Free AI Powered Buy and Sell Recommendations - moha.gov.vn

Dec 12, 2025
pulisher
Dec 09, 2025

Entera Bio (NASDAQ:ENTX) Trading Down 0.9%Here's What Happened - MarketBeat

Dec 09, 2025
pulisher
Dec 05, 2025

Entera Bio Ltd. (ENTX) Drops 5% in Pre-market: No Clear Catalyst - Stocks Telegraph

Dec 05, 2025
pulisher
Dec 05, 2025

Is Entera Bio Ltd. (5DT) stock dividend growth reliableJuly 2025 Intraday Action & Precise Entry and Exit Recommendations - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Why Entera Bio Ltd. (5DT) stock appeals to dividend investorsQuarterly Portfolio Report & Smart Swing Trading Techniques - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Will Entera Bio Ltd. (5DT) stock sustain uptrend momentumStop Loss & Long-Term Safe Investment Ideas - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Will Entera Bio Ltd. (5DT) stock benefit from infrastructure billMarket Activity Summary & Capital Protection Trade Alerts - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Is Entera Bio Ltd. (5DT) stock good for wealth creationEarnings Trend Report & Reliable Entry Point Trade Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Entera Bio Ltd. (5DT) stock sustain revenue momentumWeekly Market Report & Risk Controlled Daily Trade Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Entera Bio Ltd. (5DT) stock issue positive guidanceJuly 2025 Market Mood & AI Driven Stock Price Forecasts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Entera Bio Ltd. (5DT) stock enhance shareholder valueJuly 2025 Spike Watch & Low Risk High Win Rate Picks - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

How Entera Bio Ltd. (5DT) stock expands through international marketsRate Cut & Weekly Chart Analysis and Trade Guides - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will Entera Bio Ltd. (5DT) stock hit analyst forecasts2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Can Entera Bio Ltd. (5DT) stock expand revenue streams2025 Short Interest & High Return Trade Guides - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How Entera Bio Ltd. stock performs in stagflation2025 Volatility Report & Growth Focused Entry Point Reports - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Can Entera Bio Ltd. (5DT) stock surprise markets with earningsTrend Reversal & Reliable Volume Spike Alerts - Newser

Dec 02, 2025

Entera Bio Ltd (ENTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$102.71
price up icon 28.63%
$33.90
price up icon 2.42%
$110.57
price up icon 3.67%
$100.08
price up icon 2.03%
biotechnology ONC
$333.87
price up icon 4.22%
$176.00
price up icon 0.53%
자본화:     |  볼륨(24시간):